Two regions of the mouse mammary tumor virus long terminal repeat regulate the activity of its promoter in mammary cell lines

In vivo expression of the mouse mammary tumor virus (MMTV) is restricted to a few organs, with the highest rate of transcription found in the mammary gland. Using a series of mammary and nonmammary murine cell lines, we have identified two regulatory elements, located upstream of the hormone responsive element, that specifically regulate the MMTV promoter. The first element displays an enhancerlike activity and is coincident with the binding of a nuclear factor (designated MP4; position -1078 to -1052 in the long terminal repeat) whose presence is apparently restricted to mammary cell lines. The second regulatory region mediates a repressive activity and is mapped to the long terminal repeat segment from -415 to -483. This repression is specific for a particular subtype of mammary cells (RAC cells) able to grow under two differentiation states (A. Sonnenberg, H. Daams, J. Calafat, and J. Hilgers, Cancer Res. 46:5913-5922, 1986). The MMTV promoter in mammary cell lines thus appears to be modulated by two cis-acting elements that are likely to be involved in tissue-specific expression in vivo.

[1]  J. Sambrook,et al.  Molecular Cloning: A Laboratory Manual , 2001 .

[2]  R. Nusse,et al.  The Wnt-1 (int-1) oncogene promoter and its mechanism of activation by insertion of proviral DNA of the mouse mammary tumor virus , 1990, Molecular and cellular biology.

[3]  H. Tanaka,et al.  Extra mouse mammary tumor proviruses in DBA/2 mouse lymphomas acquire a selective advantage in lymphocytes by alteration in the U3 region of the long terminal repeat , 1990, Journal of virology.

[4]  H. Ponta,et al.  The long terminal repeat region of the mouse mammary tumour virus contains multiple regulatory elements. , 1990, Nucleic acids research.

[5]  P. Leder,et al.  The int‐2 gene product acts as an epithelial growth factor in transgenic mice. , 1990, The EMBO journal.

[6]  G. Peters,et al.  Proviral insertions within the int-2 gene can generate multiple anomalous transcripts but leave the protein-coding domain intact , 1990, Journal of virology.

[7]  P. Leder,et al.  Animal models of human disease. Pathology and molecular biology of spontaneous neoplasms occurring in transgenic mice carrying and expressing activated cellular oncogenes. , 1989, The American journal of pathology.

[8]  H. Diggelmann,et al.  Dual function of a nuclear factor I binding site in MMTV transcription regulation. , 1989, Nucleic acids research.

[9]  P. Lefebvre,et al.  Association of the glucocorticoid receptor binding subunit with the 90K nonsteroid-binding component is stabilized by both steroidal and nonsteroidal antiglucocorticoids in intact cells. , 1988, Biochemistry.

[10]  J. Dudley,et al.  Mouse mammary tumor virus proviruses in T-cell lymphomas lack a negative regulatory element in the long terminal repeat , 1988, Journal of virology.

[11]  R. Nusse.  The int genes in mammary tumorigenesis and in normal development. , 1988, Trends in genetics : TIG.

[12]  Michael C. Ostrowski,et al.  Negative regulation of transcription in vitro by a glucocorticoid response element is mediated by a trans-acting factor , 1988, Molecular and cellular biology.

[13]  S. Ross,et al.  Endogenous mouse mammary tumor virus is expressed in several organs in addition to the lactating mammary gland , 1988, Journal of virology.

[14]  P. Waight,et al.  Alterations in the U3 region of the long terminal repeat of an infectious thymotropic type B retrovirus , 1988, Journal of virology.

[15]  D. Roop,et al.  Transcriptional control of high molecular weight keratin gene expression in multistage mouse skin carcinogenesis. , 1988, Cancer research.

[16]  H. Ponta,et al.  DNA sequences outside the receptor‐binding sites differently modulate the responsiveness of the mouse mammary tumour virus promoter to various steroid hormones. , 1988, The EMBO journal.

[17]  S. Nordeen,et al.  Luciferase reporter gene vectors for analysis of promoters and enhancers. , 1988, BioTechniques.

[18]  T. A. Stewart,et al.  Multiple regulatory domains in the mouse mammary tumor virus long terminal repeat revealed by analysis of fusion genes in transgenic mice , 1988, Molecular and cellular biology.

[19]  K. Morley,et al.  Transcriptional repression of a hormone-responsive promoter. , 1987, Nucleic acids research.

[20]  J. Nowock,et al.  Interaction of the TGGCA‐binding protein with upstream sequences is required for efficient transcription of mouse mammary tumor virus. , 1987, The EMBO journal.

[21]  K. Wood,et al.  Firefly luciferase gene: structure and expression in mammalian cells , 1987, Molecular and cellular biology.

[22]  G. Hager,et al.  Steroid-dependent interaction of transcription factors with the inducible promoter of mouse mammary tumor virus in vivo , 1987, Cell.

[23]  A. Sonnenberg,et al.  Oncogene expression during progression of mouse mammary tumor cells; activity of a proviral enhancer and the resulting expression of int‐2 is influenced by the state of differentiation. , 1987, The EMBO journal.

[24]  A. Sonnenberg,et al.  In vitro differentiation and progression of mouse mammary tumor cells. , 1986, Cancer research.

[25]  R. Michalides,et al.  Site-specific rearrangements in the long terminal repeat of extra mouse mammary tumor proviruses in murine T-cell leukemias. , 1986, Virology.

[26]  R. Wellinger,et al.  Exogenous mouse mammary tumor virus proviral DNA isolated from a kidney adenocarcinoma cell line contains alterations in the U3 region of the long terminal repeat , 1986, Journal of virology.

[27]  G. Peters,et al.  Sequence, topography and protein coding potential of mouse int‐2: a putative oncogene activated by mouse mammary tumour virus. , 1986, The EMBO journal.

[28]  R. Wellinger,et al.  A new site of integration for mouse mammary tumor virus proviral DNA common to BALB/cf(C3H) mammary and kidney adenocarcinomas. , 1986, The EMBO journal.

[29]  D. Solter,et al.  Glucocorticoid regulation of mouse mammary tumor virus sequences in transgenic mice. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[30]  R. Michalides,et al.  Rearrangements in the long terminal repeat of extra mouse mammary tumor proviruses in T-cell leukemias of mouse strain GR result in a novel enhancer-like structure , 1985, Molecular and cellular biology.

[31]  R. Nusse,et al.  Structure and nucleotide sequence of the putative mammary oncogene int-1; proviral insertions leave the protein-encoding domain intact , 1984, Cell.

[32]  B. Groner,et al.  The methylation pattern of endogenous mouse mammary tumor virus proviral genes is tissue specific and stably inherited. , 1984, Virology.

[33]  R. King,et al.  Progression to steroid autonomy in S115 mouse mammary tumor cells: role of DNA methylation , 1984, The Journal of cell biology.

[34]  M. Ehrlich,et al.  Mouse mammary tumor virus DNA methylation: tissue-specific variation. , 1984, Virology.

[35]  G. Peters,et al.  Tumorigenesis by mouse mammary tumor virus: Proviral activation of a cellular gene in the common integration region int-2 , 1984, Cell.

[36]  D. Cox,et al.  Mode of proviral activation of a putative mammary oncogene (int-1) on mouse chromosome 15 , 1984, Nature.

[37]  H. Richard-Foy,et al.  Glucocorticoid regulation of transcription at an amplified, episomal promoter , 1983, Molecular and cellular biology.

[38]  R. Schleenbaker,et al.  Activation of covalent affinity labeled glucocorticoid receptor-steroid complexes. , 1983, The Journal of biological chemistry.

[39]  R. Schleenbaker,et al.  Affinity labeling of the rat liver glucocorticoid receptor with dexamethasone 21-mesylate. Identification of covalently labeled receptor by immunochemical methods. , 1981, The Journal of biological chemistry.

[40]  L. Donehower,et al.  Regulatory and coding potential of the mouse mammary tumor virus long terminal redundancy , 1981, Journal of virology.

[41]  J. Cohen,et al.  Methylation of milk-borne and genetically transmitted mouse mammary tumor virus proviral DNA , 1980, Cell.

[42]  Tom Maniatis,et al.  Transformation of mammalian cells with genes from procaryotes and eucaryotes , 1979, Cell.

[43]  M. M. Bradford.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. , 1976, Analytical biochemistry.

[44]  E. Scolnick,et al.  High frequency variation in mammary tumor virus expression in cell culture , 1976, Cell.

[45]  B. Hogan,et al.  Development of mammary hyperplasia and neoplasia in MMTV-TGF alpha transgenic mice. , 1990, Cell.

[46]  G. Hager.  MMTV as a model for gene expression in mammary tissue. , 1988, Cancer treatment and research.

[47]  C. Dickson.  Molecular aspects of mouse mammary tumor virus biology. , 1987, International review of cytology.

[48]  R. Roeder,et al.  Eukaryotic gene transcription with purified components. , 1983, Methods in enzymology.

[49]  L. Donehower,et al.  Construction and characterization of molecular clones containing integrated mouse mammary tumor virus sequences. , 1980, Cold Spring Harbor symposia on quantitative biology.